14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
Over the past several weeks, the novel coronavirus (COVID-19) has upended the marketplace and impose...
Read More >
In a legal challenge to a corporate transaction, the applicable standard of review is often outcome ...
Read More >
The New Jersey Department of Labor and Workforce Development (“NJDOL”) recently issued final regul...
Read More >
EPA limits states’ power to review projects that affect water quality - Bullet Courthouse News Se...
Read More >
As the novel coronavirus, known as COVID-19, and the associated illness spreads around the world and...
Read More >
On February 13, 2020, the California Supreme Court struck a blow to brick and mortar retailers in th...
Read More >